Next Article in Journal
Novel Design of Neuropeptide-Based Drugs with β-Sheet Breaking Potential in Amyloid-Beta Cascade: Molecular and Structural Deciphers
Next Article in Special Issue
Nutraceutical-Based Nanoformulations for Breast and Ovarian Cancer Treatment
Previous Article in Journal
NSAID-Based Coordination Compounds for Biomedical Applications: Recent Advances and Developments
Previous Article in Special Issue
Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 23
Issue 5
10.3390/ijms23052856
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management

by
Priti Tagde
1,
Agnieszka Najda
2,*,
Kalpana Nagpal
1,
Giriraj T. Kulkarni
3,
Muddaser Shah
4,
Obaid Ullah
4,
Sebastian Balant
2 and
Md. Habibur Rahman
5,*
1
Amity Institute of Pharmacy, Amity University, Noida 201301, India
2
Department of Vegetable and Herbal Crops, University of Life Sciences in Lublin, 50A Doświadczalna Street, 20-280 Lublin, Poland
3
Gokaraju Rangaraju College of Pharmacy, Bachupally, Hyderabad 500090, India
4
Natural and Medical Sciences Research Center, University of Nizwa, P.O. Box 33, Birkat Mauz, Nizwa 616, Oman
5
Department of Global Medical Science, Wonju College of Medicine, Yonsei University, Wonju 26426, Korea
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2022, 23(5), 2856; https://doi.org/10.3390/ijms23052856
Submission received: 18 January 2022 / Revised: 3 March 2022 / Accepted: 3 March 2022 / Published: 5 March 2022
(This article belongs to the Special Issue Nano-Strategies: The Future Medicine for Fighting Cancer Progression and Drug Resistance 2.0)
Browse Figures
Versions Notes

Abstract

Breast cancer is one of the most common types of cancer among women globally. It is caused by mutations in the estrogen/progesterone receptors and conventional treatment methods are commonly utilized. About 70–80 percent of individuals with the early-stage non-metastatic disease may be cured. Conventional treatment is far less than the optimal ratio, as demonstrated through the high mortality rate of women with this cancer. However, conventional treatment methods like surgery, radiotherapy, and chemotherapy are not as effective as expected and lead to concerns about low bioavailability, low cellular uptake, emerging resistance, and adverse toxicities. A nanomedicine-based approach is a promising alternative for breast cancer treatment. The present era is witnessing rapid advancements in nanomedicine as a platform for investigating novel therapeutic applications and modern intelligent healthcare management strategies. This paper focuses on nanomedicine-based therapeutic interventions that are becoming more widely accepted for improving treatment effectiveness and reducing undesired side effects in breast cancer patients. By evaluating the state-of-the-art tools and taking the challenges involved into consideration, various aspects of the proposed nano-enabled therapeutic approaches have been discussed in this review.
Keywords: nanomedicine; drug therapy; breast cancer; targeted delivery; drug resistance; combinational approach nanomedicine; drug therapy; breast cancer; targeted delivery; drug resistance; combinational approach
Graphical Abstract

Share and Cite

MDPI and ACS Style

Tagde, P.; Najda, A.; Nagpal, K.; Kulkarni, G.T.; Shah, M.; Ullah, O.; Balant, S.; Rahman, M.H. Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management. Int. J. Mol. Sci. 2022, 23, 2856. https://doi.org/10.3390/ijms23052856

AMA Style

Tagde P, Najda A, Nagpal K, Kulkarni GT, Shah M, Ullah O, Balant S, Rahman MH. Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management. International Journal of Molecular Sciences. 2022; 23(5):2856. https://doi.org/10.3390/ijms23052856

Chicago/Turabian Style

Tagde, Priti, Agnieszka Najda, Kalpana Nagpal, Giriraj T. Kulkarni, Muddaser Shah, Obaid Ullah, Sebastian Balant, and Md. Habibur Rahman. 2022. "Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management" International Journal of Molecular Sciences 23, no. 5: 2856. https://doi.org/10.3390/ijms23052856

APA Style

Tagde, P., Najda, A., Nagpal, K., Kulkarni, G. T., Shah, M., Ullah, O., Balant, S., & Rahman, M. H. (2022). Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management. International Journal of Molecular Sciences, 23(5), 2856. https://doi.org/10.3390/ijms23052856

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop